Pharmacokinetic (PK) analysis of fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) following triple therapy at two UMEC doses in healthy subjects

被引：0
|
作者：
Henderson, A.
Allen, A.
Gupta, A.
Renaux, J.
Brealey, N.
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Bronchodilators; COPD; -; management; Pharmacology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P938
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI in inadequately controlled asthma: the CAPTAIN study
    Pavord, Ian
    Peachey, Guy
    Kerstjens, Huib
    Kerwin, Edward
    Nathan, Robert
    Hanania, Nicola A.
    Pascoe, Steven
    Fowler, Andrew
    Bailes, Zelie
    Edwards, Dawn
    Sule, Neal
    Barnes, Neil
    Boulet, Louis-Philippe
    Tabberer, Maggie
    Lee, Laurie A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (06) : 459 - 460
  • [22] GENETIC VARIANTS DO NOT PREDICT ACUTE COPD EXACERBATIONS OR TREATMENT RESPONSE TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) AND ITS COMPONENTS
    Hosking, Louise
    Yeo, Astrid
    Hoffman, Joshua
    Chiano, Mathias
    Fraser, Dana
    Ghosh, Soumitra
    Lipson, David
    Martin, Neil
    Condreay, Lynn
    Cox, Charles
    Stjean, Pamela
    CHEST, 2020, 158 (04) : 1800A - 1801A
  • [23] Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
    Ismaila, Afisi S.
    Rothnie, Kieran J.
    Wood, Robert P.
    Banks, Victoria L.
    Camidge, Lucinda J.
    Czira, Alexandrosz
    Compton, Chris
    Sharma, Raj
    Millard, Shannon N.
    Massey, Olivia
    Halpin, David M. G.
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [24] Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
    Afisi S. Ismaila
    Kieran J. Rothnie
    Robert P. Wood
    Victoria L. Banks
    Lucinda J. Camidge
    Alexandrosz Czira
    Chris Compton
    Raj Sharma
    Shannon N. Millard
    Olivia Massey
    David M. G. Halpin
    Respiratory Research, 24
  • [25] Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers
    Brealey, Noushin
    Gupta, Ashutosh
    Renaux, Jessica
    Mehta, Rashmi
    Allen, Ann
    Henderson, Alex
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (09) : 753 - 764
  • [26] Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study
    Afisi S. Ismaila
    Kieran J. Rothnie
    Robert P. Wood
    Victoria L. Banks
    Lucinda J. Camidge
    Alexandrosz Czira
    Chris Compton
    Raj Sharma
    Shannon N. Millard
    Olivia Massey
    David M. G. Halpin
    Respiratory Research, 25
  • [27] ARE PATIENTS WITH COPD MORE ADHERENT TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) COMPARED WITH MULTIPLE-INHALER TRIPLE THERAPY IN A REAL-WORLD UK PRIMARY CARE TREATED POPULATION?
    Halpin, D. M. G.
    Rothnie, K. J.
    Banks, V.
    Czira, A.
    Compton, C.
    Wood, R.
    Tritton, T.
    Massey, O.
    Wild, R.
    Snowise, N.
    Gubba, E.
    Sharma, R.
    Ismaila, A. S.
    Vogelmeier, C. F.
    THORAX, 2021, 76 : A20 - A21
  • [28] Captain Study: Treatable Traits and the Outcome of Treatment with Inhaled Fluticasone Furoate/Umeclidinium/Vilanterol ( FF/UMEC/VI) Versus FF/VI Therapies in Patients with Uncontrolled Asthma, A Pre-Specified Subgroup Analysis
    Pavord, I. D.
    Fowler, A.
    Kerstjens, H.
    Papi, A.
    Hartley, B.
    Goldfrad, C.
    Barnes, N.
    Oppenheimer, J.
    Pizzichini, E.
    Lee, L. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [29] Captain Study: Daily Digital Spirometry and Symptom Data for Once-Daily, Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Asthma
    Lee, L.
    Boulet, L.
    Fowler, A.
    Tabberer, M.
    Bailes, Z.
    Pascoe, S.
    Kerwin, E. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [30] Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
    Baptist, Alan P.
    Germain, Guillaume
    Klimek, Jacob
    Laliberte, Francois
    Schell, Robert C.
    Forero-Schwanhaeuser, Sergio
    Moore, Alison
    Noorduyn, Stephen G.
    Paczkowski, Rosirene
    ADVANCES IN THERAPY, 2025, 42 (02) : 1061 - 1074
12345